Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Review

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

      
Total article views   HTML views PDF downloads Totals
17,286 Dovepress* 13,479+ 2,411 15,890
PubMed Central* 3,807 785 4,592
Totals 17,286 3,196 20,482
*Since 10 November 2010
+Since July 2016

View citations on PubMed Central and Google Scholar